Concepedia

Hitoshi Kohayakawa

HK

3

Publications

172

Citations

3

H-Index

2004

Active since

Affiliations

Sumitomo Dainippon Pharma (Japan)(Current)

Hitoshi Kohayakawa is an author at Sumitomo Dainippon Pharma (Japan) specializing in neuropharmacology, pharmacotherapy, and medicine.

Top concepts

MedicinePharmacologyPharmacotherapyNeuropharmacologyNeuroscienceDrug DiscoveryMolecular PharmacologyNeurologyDepressionImmunology

Publications per year

2004–2014

3

Publications

3

Antianxiety and antidepressant‐like effects of AC‐5216, a novel mitochondrial benzodiazepine receptor ligand

Atsuko Kita, Hitoshi Kohayakawa, Tomoko Kinoshita et al. · British Journal of Pharmacology · 2004 · 127 citations · Full text

Conventional Benzodiazepines, Psychotropic Medication, Psychopharmacology +17

Lack of tolerance to anxiolysis and withdrawal symptoms in mice repeatedly treated with AC-5216, a selective TSPO ligand

Atsuko Kita, Tomoko Kinoshita, Hitoshi Kohayakawa et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2009 · 34 citations

Medicine, Immunology, Selective Tspo Ligand +7

In vivo pharmacological characterization of AC-3933, a benzodiazepine receptor partial inverse agonist for the treatment of Alzheimer’s disease

Yuki Hatayama, Takashi Hashimoto, Hitoshi Kohayakawa et al. · Neuroscience · 2014 · 11 citations

Molecular Pharmacology, Alzheimer's Disease, Medicine +10

Rows per page

1–3 of 3